Wolf Lisa G reported VBIO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001683168-26-007396

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 18, 2026

Published

Sep 24, 2026

Ingested by INSIDER

Nov 5, 02:15 UTC

Last re-read

Nov 5, 02:15 UTC

Extracted facts

Filer

Wolf Lisa G

Role

COO & CFO

Transaction

Option exerciseAs filed: “M”

Asset

Valion Bio, Inc.

Ticker

VBIO

Shares

4

Execution date (reported)

Sep 18, 2026

Owned after transaction

29 shares

Days from execution to publication

6

What this establishes

Wolf Lisa G filed this Form 4 reporting a option exercise of VBIO on Sep 18, 2026. It became public on Sep 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

COO & CFO

Wolf Lisa Gcik:0001861556

Issuer

Valion Bio, Inc.cik:0001787740

Revision history · 0

No field has changed since this record was first ingested.